Vaccination

Emerging protein-based COVID-19 vaccines could be game-changing

Current messenger RNA vaccines appear to offer at least some protection against new SARS-CoV-2 variants, including omicron, especially for people who have received boosters. But manufacturing costs and the need for ultra-cold ...

Oncology & Cancer

Porous cells lead to poorer livers

Need another reason to think twice before ordering that extra helping of fries? It could lead to a higher risk of developing liver cancer. Cases of nonalcoholic steatohepatitis (NASH)—a type of fatty liver disease that ...

Immunology

Immune response may vary with choice of COVID-19 booster

(HealthDay)—Immune response may vary with the choice of COVID-19 vaccine used for a third dose or booster following two doses of ChAdOx1 nCoV-19 (ChAd) or Pfizer BioNTech BNT162b2 (BNT), according to a study published online ...

page 5 from 40